ISRCTN72406488进行中（未招募）Unknown
The ADAPT randomised controlled trial: Adapting, Disease self-management and Acknowledgement by Psychosocial Targeted interventions for rheumatology patients
niversity of Cambridge0 个研究点目标入组 920 人开始时间: 2023年3月29日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 920
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged 18 years or over
- •2. Resident in the UK or Ireland
- •3.1. Phase 1: Have SLE (lupus) as a diagnosis on clinic letters
- •3.2. Phase 2: Have any Systemic autoimmune rheumatic diseases (SARD) as a diagnosis on clinic letters
排除标准
- •1. Aged under 18 years
- •2. Not resident in the UK or Ireland.
- •3. Not having SLE (lupus) for phase 1 or any systemic rheumatic disease for phase 2.
研究者
相似试验
进行中（未招募）
3 期
Trial exploring the benefits of different doses of baclofen for patients with alcohol addictioISRCTN17435333niversity of Liverpool400
进行中（未招募）
Unknown
earning Together Primary Schools pilot randomized controlled trialPrevention of bullying among primary school studentsISRCTN10215449ondon School of Hygiene & Tropical Medicine1,059
招募中
不适用
The AdaptResponse clinical studyheart decompensationHeartfailure10019280NL-OMON53104Medtronic Bakken Research Center150
已完成
不适用
AdaptResponse Clinical StudyHeart FailureJPRN-UMIN000015371Medtronic Japana Co., Ltd.3,800
进行中（未招募）
不适用
A randomized, adaptive-design dose finding study to assess the antiviral efficacy andsafety of NIM811 administered in combination with Standard of Care (SOC) for 12 weeks in relapsed HCV-1 infected patientsEUCTR2009-009995-11-DEovartis Pharma Services AG50